Optimal subcutaneous formulations of ketamine would have a pH and osmolality close to physiological levels without compromising on concentration or injection volume; the same strategy has potential to be readily adapted to other amine-based APIs.
Optimal subcutaneous formulations of ketamine would have a pH and osmolality close to physiological levels without compromising on concentration or injection volume; the same strategy has potential to be readily adapted to other amine-based APIs.